公司资料
Ocean Biomedical 股价、新闻与催化剂
- 股票代码:
- OCEA
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.00 USD (0.00%)
收盘价
最后更新: 2026年10月1日
—
市值
股价为何变动
截至 2026年10月1日，OCEA 股价变化不大，收于 $0.0008。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Ocean Biomedical is a biotech company that has pursued multiple discovery and development directions, often with a focus on novel cancer and inflammatory disease concepts. Its identity has been shaped by platform ambition and capital markets evolution.
所在地与行业分类
Ocean Biomedical is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotechnology.
商业模式特征
The company depends on strategic focus, scientific validation, and capital efficiency. Investors usually watch corporate restructuring, pipeline prioritization, and funding.
生物医药行业定位
Ocean Biomedical occupies a speculative small-cap biotech niche. The stock is driven more by strategy and financing than by mature commercial execution.
未来催化剂
- Ocean Biomedical is largely a legacy / closeout story, so the catalysts are any strategic or asset-resolution update rather than a live pipeline milestone. The market is focused on residual value.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。